Henry Schein Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Henry Schein Inc 's inventory turnover ratio sequentially decreased to 4.68 in the second quarter 2026, unsurprisingly, as the Henry Schein Inc markets continue to deteriorate, and HSIC's faces growing challenges to bring down its inventories. Average processing period, for Henry Schein Inc 's inventories remained unchanged at 78 days, in the Jun 27 2026 quarter.

Within Healthcare sector 81 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 534 in the first quarter 2026, to 827.

HSIC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Henry Schein Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HSIC Inventory Turnover Ratio	(Jun 27 2026) II. Quarter	(Mar 28 2026) I. Quarter	(Dec 27 2025) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter
Y / Y Inventory Growth	7.91 %	9.34 %	10.61 %	9.01 %	15.15 %
Y / Y Cost of Sales Growth	5.98 %	6 %	8.01 %	6.05 %	5 %
Inventory Turnover Ratio (TTM)	4.68	4.7	4.74	4.77	4.8
HSIC's Total Ranking	# 827	# 534	# 497	# 550	# 550
Average inventory processing period	78	78	77	77	76
Seq. Inventory Growth	2.23 %	0.6 %	4.71 %	0.21 %	3.58 %
Seq. Cost of Sales Growth	2.57 %	-3.2 %	2.64 %	4 %	2.58 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 32
Healthcare Sector	# 82
Overall Market	# 827

Inventory Turnover Ratio Statistics
High	Average	Low
10.4	5.38	3.69
(Dec 28 2013)		(Sep 29 2018)

HSIC Company Profile >> Back to HSIC Efficiency Comparisons >> Compare HSIC Inventory Turnover Ratio to its Competitors

Financial Statements
Henry Schein Inc 's Inventories	$ 2,059 Millions	Visit HSIC's Balance sheet
Henry Schein Inc 's Cost of Revenues TTM	$ 9,342 Millions	Visit HSIC's Income Statement
What are HSIC's Sales?		Visit HSIC's Sales by Segment

Other Inventory Turnover Ratios
Henry Schein Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HSIC's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HSIC's Competitors
Inventory Turnover Ratio for HSIC's Suppliers
Inventory Turnover Ratio for HSIC's Customers

You may also want to know
HSIC's Sales Growth Rates	HSIC's Pe Price to earnings ratio	HSIC's Receivables Turnover Ratio	HSIC's Stock Quote
HSIC's Net Income Growth Rates	HSIC's Ps Price to Sales ratio	HSIC's Sales per Employee	HSIC's Asset Turnover Ratio
HSIC's Net Margin	HSIC's Pb Price to Book ratio	HSIC's Financial Strength Ratios	HSIC's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 27 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 27 2026	Inventories at quarter ending Jun 27 2026
Earth Science Tech Inc	11.64	$ 8.974 Millions	$ 1 Millions
Alnylam Pharmaceuticals Inc	11.45	$ 970.735 Millions	$ 85 Millions
Infusystem Holdings Inc	10.92	$ 60.985 Millions	$ 6 Millions
Irhythm Holdings Inc	10.79	$ 235.967 Millions	$ 22 Millions
Genedx Holdings Corp	10.27	$ 140.202 Millions	$ 14 Millions
Tarsus Pharmaceuticals Inc	10.20	$ 43.740 Millions	$ 4 Millions
Lantheus Holdings Inc	10.09	$ 619.325 Millions	$ 61 Millions
Sotera Health Company	10.04	$ 547.412 Millions	$ 55 Millions
Natera Inc	9.46	$ 672.186 Millions	$ 71 Millions
Warby Parker Inc	9.27	$ 414.054 Millions	$ 45 Millions
Hims and Hers Health Inc	9.23	$ 814.411 Millions	$ 88 Millions
Polomar Health Services, Inc.	8.80	$ 1.233 Millions	$ 0 Millions
Myriad Genetics Inc	8.31	$ 250.700 Millions	$ 30 Millions
National Vision Holdings Inc	8.26	$ 841.416 Millions	$ 102 Millions
Castle Biosciences Inc	8.14	$ 81.252 Millions	$ 10 Millions
Autolus Therapeutics Plc	8.08	$ 99.009 Millions	$ 12 Millions
The Oncology Institute Inc	8.03	$ 160.655 Millions	$ 20 Millions
Nutriband Inc	7.92	$ 1.082 Millions	$ 0 Millions
Novavax inc	7.61	$ 88.541 Millions	$ 12 Millions
Inogen Inc	7.51	$ 196.617 Millions	$ 26 Millions
Moderna Inc	7.50	$ 1,707.000 Millions	$ 228 Millions
Cardiff Lexington Corporation	7.49	$ 4.042 Millions	$ 1 Millions
Pulse Biosciences Inc	7.45	$ 1.182 Millions	$ 0 Millions
Vanda Pharmaceuticals Inc	7.43	$ 13.506 Millions	$ 2 Millions
Carlsmed Inc	7.42	$ 13.955 Millions	$ 2 Millions
Adaptive Biotechnologies Corporation	7.26	$ 75.254 Millions	$ 10 Millions
Lifemd Inc	7.22	$ 22.284 Millions	$ 3 Millions
Phathom Pharmaceuticals Inc	7.01	$ 40.929 Millions	$ 6 Millions
Precision Optics Corporation Inc	6.97	$ 26.101 Millions	$ 4 Millions
Carlisle Companies Incorporated	6.94	$ 3,299.600 Millions	$ 476 Millions

Date modified: 2026-10-15T05:23:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.